Funding Rounds
Phagenesis

Phagenesis Series B (2011, $7M)

Phagenesis

Developer of neurostimulation system to treat swallowing dysfunction.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $7.60M

Raised Date: 2011-04-01

Investors